MENU

ARTH

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

Arch Therapeutics (ARTH) Ownership - Who owns Arch Therapeutics?

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

235 Walnut Street

Phone

+1 617 431-2313

Employees

8

Web

https://www.archtherapeutics.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

2.22M

P/E Ratio

N/A

Total Cash

30.03K

Projected Growth

N/A

Total Debt

9.39M

Revenue

148.16K

Risk (Beta)

6.39

Dividend Yield

N/A

Total Cash/Share

0.01

Total Debt/Equity

N/A

Revenue/Share

0.03 USD as % of share price

Fundamentals

ARTH

Capitalization

2.22M

P/E Ratio

N/A

Risk (Beta)

6.39

Dividend Yield

N/A

Total Cash

30K

Total Cash/Share

0.01

Total Debt

9.39M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.03%

Revenue

148K

ROE

N/A

Book Value

-12.56M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-1.01

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

4.44K

Current Ratio

0.10

Current Revenue Per Employee

3864.13

Dividends Per Share - Security

N/A

EBITDA

-8.68M

Float

N/A

Float - Current

N/A

Gross Income Margin

31.81

Revenue To Assets

-828.03

Shares Held By Institutions

0

Shares Outstanding - Current

4.44M

Total Liabilities

14M

Total Volume MTD

N/A

Value

-1

Gain YTD

-96.409

View a ticker or compare two or three

VS

VS

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

235 Walnut Street

Phone

+1 617 431-2313

Employees

8

Web

https://www.archtherapeutics.com